IL1B and type 2 diabetes mellitus: Moreover, the presence of elevated IL-1Ra in T2DM + DR, an anti-inflammatory receptor antagonist, may reflect a compensatory response to chronic IL-1β activity, as proposed in other models of neuroinflammation [56,57].